48
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Molecular Cytogenetic Approach to the Diagnosis of Splenic Lymphoma: A Case Report of Blastoid Mantle Cell Lymphoma

, , , , , & show all
Pages 1229-1234 | Accepted 26 Nov 2002, Published online: 03 Aug 2009

References

  • Jaffe, ES., Harris, Ni., Stein, H. and Vardiman, J.W. (2001) Pathology and Genetics of Tumours of Haematopoietic and Lymfoid Tissues (IARC Press, Lyon).
  • Pittaluga, S., Verhoef, G., Criel, A., Wlodarska, I., Dierlamm, J., Mecucci, C., Van den Berghe, H. and De Wolf-Peeters, C. (1996) "'Small' B-cell non-Hodgkin's lymphomas with splenomegaly at presentation are either mantle cell lymphoma or marginal zone cell lymphoma. A study based on histology, cytology, immunohisto-chemistry, and cytogenetic analysis", American Journal of Surgical Pathology 20, 211–223.
  • Pins, M.A., Mollejo, M., Campo, E., Menarguez, J., Flores, T. and Isaacson, P.G. (1998) "A marginal zone pattern may be found in different varieties of non-Hodgkin's lymphoma: the morphology and innnunohistology of splenic involvement by B-cell lymphomas simulating splenic marginal zone lymphoma", Histopathology 33, 230–239.
  • Swerdlow, S.H. (1999) "Small B-cell lymphomas of the lymph nodes and spleen: practical insights to diagnosis and pathogenesis", Modern Pathology 12, 125–140.
  • Li, J.Y., Gaillard, F., Moreau, A., Harousseau, J.L., Laboisse, C., Milpied, N., Bataille, R. and Avet-Loiseau, H. (1999) "Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization", American Journal of Pathology 154, 1449–1452.
  • Savilo, E., Campo, E., Mollejo, M., Pinyol, M., Pins, M.A., Zukerberg, L.R., Yang, W.I., Koelliker, D.D., Nguyen, P.L. and Harris, N.L. (1998) "Absence of cyclin D1 protein expression in splenic marginal zone lymphoma", Modern Pathology 11, 601–606.
  • Miranda, R.N., Briggs, R.C., Kinney, M.C., Veno, P.A., Hammer, R.D. and Cousar, LB. (2000) "Immunohistochemical detection of cyclin D1 using optimized conditions is highly specific for mantle cell lymphoma and hairy cell leukemia", Modern Pathology 13, 1308–1314.
  • Nordgren, A., Sorensen, A.G., Tinggaard-Pedersen, N., Blennow, E., Larsson, C. and Lagercrantz, S. (2000) "New chromosomal breakpoints in non-Hodgkin's lymphomas revealed by spectral karyotyping and G-banding", International Journal of Molecular Medicine 5, 485–492.
  • Mollejo, M., Lloret, E., Solares, J., Bergua, J.M., Mateo, M. and Pins, M.A. (1999) "Splenic involvement by blastic mantle cell lymphoma (large cell/anaplastic variant) mimicking splenic marginal zone lymphoma", American Journal of Hematology 62, 242–246.
  • Lennert, K., Stein, H. and Kaiserling, E. (1975) "Cytological and functional criteria for the classification of malignant lymphomata", British Journal of Cancer 31, 29–43.
  • Harris, N.L., Jaffe, ES., Stein, H., Banks, P.M., Chan, J.K., Cleary, ML., Delsol, G., De Wolf-Peeters, C., Falini, B. and Gatter, K.C. (1994) "A revised European—American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group", Blood 84, 1361–1392.
  • Williams, ME., Swerdlow, S.H., Rosenberg, C.L. and Arnold, A. (1993) "Chromosome 11 translocation breakpoints at the PRAD 1 /cyclin D1 gene locus in centrocytic lymphoma", Leukemia 7, 241 —245.
  • Suzuki, R., Takemura, K., Tsutsumi, M., Nakamura, S., Hamajima, N. and Seto, M. (2001) "Detection of cyclin D1 overexpression by real-time reverse-transcriptase-mediated quantitative polymerase chain reaction for the diagnosis of mantle cell lymphoma", American Journal of Pathology 159, 425–429.
  • Hashimoto, Y., Nakamura, N., Kuze, T., Abe, M. and Wakasa, H. (1997) "Intranuclear expression of cyclin D1 protein as a useful prognostic marker for mantle cell lymphoma", Fukushima Journal of Medical Science 43, 87–98.
  • de Boer, C.J., van Krieken, J.H., Schuuring, E. and Kluin, P.M. (1997) "Bc1-1/cyclin D1 in malignant lymphoma", Annals of Oncology 8, 109–117.
  • Yatabe, Y, Suzuki, R., Tobinai, K., Matsuno, Y, Ichinohasama, R., Okamoto, M., Yamaguchi, M., Taman', J., Uike, N., Hashimoto, Y, Morishima, Y, Suchi, T., Seto, M. and Nakamura, S. (2000) "Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin Di-positive MCL and cyclin Di-negative MCL-like B-cell lymphoma", Blood 95, 2253–2261.
  • Bosch, F., Jares, P., Campo, E., Lopez-Guillermo, A., Pins, Villamor, N., Tassies, D., Jaffe, ES., Montserrat, E., Rozman, C. and Cardesa, A. (1994) "PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma", Blood 84, 2726–2732.
  • Ravandi-Kashani, F., O'Brien, S., Manshouri, T., Lerner, S., Sim, S., Dodd, K., Kantarjian, H., Freireich, E., Keating, M. and Albitar, M. (2000) "Variations in the low levels of cyclin D1/BCL1 have prognostic value in chronic lymphocytic leukemia", Leukemia Research 24, 469–474.
  • Bijwaard, K.E., Aguilera, N.S., Monczak, Y, Trudel, M., Taubenberger, J.K. and Lichy, J.H. (2001) "Quantitative real-time reverse transcription-PCR assay for cyclin D1 expression: utility in the diagnosis of mantle cell lymphoma", Clinical Chemistry 47, 195–201.
  • Chan, J.K., Miller, K.D., Munson, P. and Isaacson, P.G. (1999) "Irmnunostaining for cyclin D1 and the diagnosis of mantle cell lymphoma: is there a reliable method?", Histopathology 34, 266–270.
  • Mitelman Database of Chromosome Aberrations in Cancer. (www http://cgap.nci.gov /chromosomes/mitelman.)
  • Gruszka-Westwood, A.M., Atkinson, S., Summersgill, B.M., Shipley, J., Elnenaei, M.O., Jain, P., Hamoudi, R.A., Kaeda, Wotherspoon, A.C., Matutes, E. and Catovsky, D. (2002) "Unusual case of leukemic mantle cell lymphoma with amplified CCND 1/IGH fusion gene", Genes, Chromosomes and Cancer 33, 206–212.
  • Hernandez, J.M., Mecucci, C., Michaux, L., Criel, A., Stul, M., Meeus, P., Wlodarska, I., Van Orshoven, A., Cassiman, J.J., De Wolf-Peeters, C. and Van den Berghe, H. (1997) "del(7q) in chronic B-cell lymphoid malignancies", Cancer Genetics and Cytogenetics 93, 147–151.
  • Arber, D.A., Rappaport, H. and Weiss, L.M. (1997) "Non-Hodgkin's lymphoproliferative disorders involving the spleen", Modern Pathology 10, 18–32.
  • Lennert, K. and Feller, A.C. (1992) Histopathology of Non-Hodgkin's Lymphoma, 2nd Ed. (Springer, Berlin).
  • No author. (1982) "National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project", Cancer, 49, 2112–2135.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.